These findings were confirmed by the increased expression of pro-apoptotic factors and a decreased expression of anti-apoptotic factor Bcl-2 in uterine leiomyoma cells after R6p-cRGD-mediated transfection. The gene discussed is BCL2; the disease is uterine corpus leiomyoma.